Levo ofloxacin derivative, its production and use

A technology of levofloxacin and derivatives, applied in the fields of levofloxacin derivatives, preparation and use thereof, can solve the symptoms of venous irritation or central nervous system reactions, adverse reactions and safety are not determined, serum trough Alanine aminotransferase increase and other problems, to achieve the effect of high crystallization rate, high safety, and complete salt formation

Inactive Publication Date: 2006-11-01
沈阳金峰医药科技有限公司 +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] Levofloxacin mesylate has strong stomach discomfort, can cause adverse reactions in the central nervous system and skin, and occasionally can cause seizures, mental disorders and intermittent nephritis, due to the adverse reactions caused by it And safety has not been determined, especially not suitable for the application of teenagers and infants under the age of 18
[0010] The clinical use of levofloxacin lactate can increase serum alanine aminotransferase, and its lactate ion can produce local irritation when injected locally, and excessive dripping speed during intravenous injection can cause venous irritation symptoms or central nervous system reactions , although most patients can tolerate it, and it can disappear on its own after the course of treatment, but after all, it causes the patient's pain during use, and clinically requires appropriate improvement.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Levo ofloxacin derivative, its production and use
  • Levo ofloxacin derivative, its production and use
  • Levo ofloxacin derivative, its production and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Synthesis of levofloxacin maleate crude product (levofloxacin and maleic acid molar ratio is 1: 1) add 20g (0.054mol) levofloxacin to 150ml absolute ethanol, heat to dissolve, Form a yellow transparent solution, weigh 6.58g (0.057mol) of maleic acid and add it to the levofloxacin ethanol solution, stir, heat, and reflux for 30 to 50 minutes, suction filter while it is hot, and wash the filter cake with absolute ethanol , dried in vacuo at 60°C to obtain the crude product of levofloxacin maleate;

Embodiment 2

[0049] Levofloxacin maleate crude product synthesis (levofloxacin and maleic acid molar ratio is 1: 0.5) 20g (0.054mol) levofloxacin is added in 140ml absolute ethanol, heated to dissolve, Form a yellow transparent solution, weigh 3.29g (0.029mol) of maleic acid and add it to the levofloxacin ethanol solution, stir, heat, and reflux for 30-50 minutes, suction filter while it is hot, and wash the filter cake with absolute ethanol , dried in vacuo at 60°C to obtain the crude product of levofloxacin maleate;

Embodiment 3

[0051] Synthesis of crude levofloxacin maleate (the molar ratio of levofloxacin to maleic acid is 1:2)

[0052] 20g (0.054mol) levofloxacin is added in 150ml absolute ethanol, is heated to dissolving, forms yellow transparent solution, then takes by weighing 13.16g (0.114mol) maleic acid and adds in levofloxacin ethanol solution, Stir, heat, and reflux for 30 to 50 minutes, suction filter while hot, wash the filter cake with absolute ethanol, and vacuum-dry at 60°C to obtain the crude product of levofloxacin maleate;

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A laevo-ofloxacin derivative, its production and use are disclosed. Its chemical molecular formula is (s)-(-)-9-fluorine-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazine)-7-oxygen7H-pyrido (1,2,3-de)(1,4)-benzoqin-6-carboxylic maleate. It can be used to treat gram-positive bacterium and gram-negative infection. It has better solubility and stability and higher crystallizing rate.

Description

technical field [0001] The invention relates to the technical field of levofloxacin derivatives of broad-spectrum antibiotics, specifically levofloxacin maleate ((s)-(-)-9-fluoro-2,3-dihydro -3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo 7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxy Acid maleate) and preparation method and application thereof, and the application of the substance (preparation) in the treatment of Gram-positive bacteria and Gram-negative bacteria infection diseases. [0002] The molecular formula is: [0003] Background technique [0004] Qunolones antibacterial drugs refer to a class of antibacterial drugs that contain a 4-quinolone core, among which fluoroquinolones have gradually become the mainstream of this class of drugs. Since the discovery of the first quinolone antibacterial drug by the Sterling-Winthrop Institute in the United States in 1962, many such drugs have appeared one after another. The antibacterial effect can be compared with the third...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D498/06A61K9/00A61K31/5383A61P31/04C07D221/00C07D265/00
Inventor 姜雪峰李祝华
Owner 沈阳金峰医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products